Andrew Do
Impact in
-
- Lung Cancer Treatments and Mutations
- Aging top 10%
- Genetics, Aging, and Longevity in Model Organisms
Papers in
-
- Lung Cancer Treatments and Mutations 19
-
- Growth Hormone and Insulin-like Growth Factors 3
- Co-authors
- William Marston Linehan (9 shared papers)Justin F. Gainor (7 shared papers)Ibiayi Dagogo‐Jack (5 shared papers)Jochen K. Lennerz (4 shared papers)Lecia Van Dam Sequist (3 shared papers)Aaron N. Hata (3 shared papers)Sai‐Hong Ignatius Ou (3 shared papers)Mari A. Mino-Kenudson (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Journal of Thoracic Oncology (3 papers)npj Precision Oncology (2 papers)ESMO Open (1 paper)GeroScience (1 paper)
- Partner nations
- United StatesGermanyPoland
In The Last Decade
Andrew Do
22 papers receiving 811 citations
Peers
Comparison fields: 5 of 47
- Pulmonary and Respiratory Medicine 617
- Aging 23
- Endocrinology, Diabetes and Metabolism 74
- Cancer Research 41
- Oncology 54
Countries citing papers authored by Andrew Do
This map shows the geographic impact of Andrew Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Do more than expected).
Fields of papers citing papers by Andrew Do
This network shows the impact of papers produced by Andrew Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Do. The network helps show where Andrew Do may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Do, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 186 | |
| 2 | 2020 | 165 | |
| 3 | 2021 | 108 | |
| 4 | 2020 | 62 | |
| 5 | 2022 | 57 | |
| 6 | 2021 | 47 | |
| 7 | 2017 | 35 | |
| 8 | 2021 | 28 | |
| 9 | 2022 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2020 | 19 | |
| 12 | 2015 | 13 | |
| 13 | 2023 | 12 | |
| 14 | 2020 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2025 | 8 | |
| 17 | 2023 | 5 | |
| 18 | 2024 | 3 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 2 |
About Andrew Do
Andrew Do is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Aging, Oncology and Cancer Research, having authored 23 papers that have together received 826 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Cancer, Hypoxia, and Metabolism (1 paper), COVID-19 and healthcare impacts (1 paper), COVID-19 Clinical Research Studies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Adipose Tissue and Metabolism (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (617 citations), Aging (23 citations), Endocrinology, Diabetes and Metabolism (74 citations), Cancer Research (41 citations) and Oncology (54 citations). Andrew Do has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include William Marston Linehan, Justin F. Gainor, Ibiayi Dagogo‐Jack, Jochen K. Lennerz, Lecia Van Dam Sequist, Aaron N. Hata, Sai‐Hong Ignatius Ou, Mari A. Mino-Kenudson, Viola Weijia Zhu and Valentina Nardi. Their work appears in journals such as Clinical Cancer Research, Journal of Thoracic Oncology, npj Precision Oncology, ESMO Open and GeroScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.